Stuart Stark, MDPhysician
- Headache Medicine
Areas of Expertise
- Headache Medicine
National Institute of Health
Epilepsy, EEG, Evoked Potentials
Neurology (Years 1-2)
Georgetown University Hospital
Neurology (Year 3)
University of Maryland Medical System Neurology
University of Maryland School of Medicine
Doctor of Medicine
Dr. Stark hails from Baltimore and lives, with his wife, in Montgomery County, Maryland. His interests include golf, cooking, sports, and spending time with family (wife, 3 sons) and friends.
Dr. Stark is Board-Certified in both Neurology and Headache Medicine and specializes in Headache Medicine. His main professional interest is diagnosing and treating patients suffering from headaches, facial pain, neck and upper back pain. His interest in Headache Medicine stems from his personal experience with severe migraine headaches beginning at age 6. Dr. Stark also evaluates patients with all neurological symptoms/conditions. His clinical skills include Nerve blocks, Trigger Point Injections, and BOTOX administration for the following diagnoses: Chronic Migraine, Cervical Dystonia, Blepharospasm, and Hemifacial Spasm. Dr. Stark has practiced in northern Virginia for 30+ years, specifically in the McLean/Tysons area since August 2012. Dr. Stark was the Director of the INOVA Headache Program prior to joining Capital Neurology Services / Privia Medical Group. Dr. Stark completed Medical School and a Medical Internship in Baltimore, at the University of Maryland School of Medicine and the University of Maryland Hospital System, respectively. Dr. Stark’s Neurology Residency was at Emory University Hospital System (2 years) and Georgetown University Hospital System (final year). He then completed a Fellowship in Epilepsy and Electroencephalography at the National Institutes of Health in Bethesda, Maryland, before entering Neurology Private Practice in Alexandria, Virginia. Dr. Stark is the authored/co-author of numerous publications in peer-reviewed medical journals and was an Investigator in more than 60 clinical trials from 1989 – 2012.